Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Clinical Treatment
100%
Treatment Outcome
100%
Myopathy
100%
Clinical Spectrum
100%
Hydroxychloroquine
100%
Muscle Biopsy
33%
Clinical Phenotype
33%
Long-term Exposure
33%
Cumulative Dose
33%
Dysphagia
33%
In(III)
16%
Cardiomyopathy
16%
Weight Loss
16%
Respiratory Failure
16%
Safety Profile
16%
Cardiac muscle
16%
Clinical Presentation
16%
Exposure Time
16%
Electromyography
16%
Myopathic
16%
Associated Morbidity
16%
Respiratory muscles
16%
Respiratory Infection
16%
Age at Presentation
16%
QT Prolongation
16%
Aspiration Pneumonia
16%
Swallowing muscles
16%
Return-to-baseline
16%
Severe Disabilities
16%
Chloroquine
16%
Cardiac Evaluation
16%
Fibrillation Potentials
16%
Acid Phosphatase
16%
Lysosomal Disease
16%
Neck Strength
16%
Rimmed Vacuoles
16%
Myotonic Discharges
16%
Muscle Toxicity
16%
Limb muscle Weakness
16%
Dose Exposure
16%
Limb Weakness
16%
Proximal Myopathy
16%
Axial Weakness
16%
Symptom Onset
16%
Laboratory Characteristics
16%
Dose-dependent
16%
Motor Unit Potential
16%
Elevated Creatine Kinase
16%
Medicine and Dentistry
Myopathy
100%
Chloroquine
100%
Hydroxychloroquine
100%
Treatment Outcome
100%
Weakness
50%
Muscle Biopsy
33%
Plummer-Vinson Syndrome
33%
Limb Weakness
33%
Neck
16%
Retrospective Study
16%
Respiratory Failure
16%
Cardiac Muscle
16%
Electromyography
16%
Morbidity
16%
Vacuolization
16%
Long Term Exposure
16%
Dose Response
16%
Creatine Kinase
16%
Respiratory Muscle
16%
Myocardial Disease
16%
Fibrillation
16%
Lipid Pneumonia
16%
Motor Unit Potential
16%
QT Prolongation
16%
Acid Phosphatase
16%
Pharmacology, Toxicology and Pharmaceutical Science
Myopathy
100%
Chloroquine
100%
Hydroxychloroquine
100%
Weakness
50%
Dysphagia
33%
Limb Weakness
33%
Respiratory Failure
16%
Long Term Exposure
16%
Morbidity
16%
Retrospective Study
16%
Myocardial Disease
16%
Creatine Kinase
16%
Aspiration Pneumonia
16%
Acid Phosphatase
16%
QT Prolongation
16%
Neuroscience
Muscle Disorder
100%
Chloroquine
100%
Hydroxychloroquine
100%
Dysphagia
33%
Motor Unit
16%
Electromyography
16%
Creatine Kinase
16%
Acid Phosphatase
16%
Myocardial Disease
16%
QT Interval
16%
Pneumonia
16%